Cargando…
Metabolomic profiles predict individual multidisease outcomes
Risk stratification is critical for the early identification of high-risk individuals and disease prevention. Here we explored the potential of nuclear magnetic resonance (NMR) spectroscopy-derived metabolomic profiles to inform on multidisease risk beyond conventional clinical predictors for the on...
Autores principales: | Buergel, Thore, Steinfeldt, Jakob, Ruyoga, Greg, Pietzner, Maik, Bizzarri, Daniele, Vojinovic, Dina, Upmeier zu Belzen, Julius, Loock, Lukas, Kittner, Paul, Christmann, Lara, Hollmann, Noah, Strangalies, Henrik, Braunger, Jana M., Wild, Benjamin, Chiesa, Scott T., Spranger, Joachim, Klostermann, Fabian, van den Akker, Erik B., Trompet, Stella, Mooijaart, Simon P., Sattar, Naveed, Jukema, J. Wouter, Lavrijssen, Birgit, Kavousi, Maryam, Ghanbari, Mohsen, Ikram, Mohammad A., Slagboom, Eline, Kivimaki, Mika, Langenberg, Claudia, Deanfield, John, Eils, Roland, Landmesser, Ulf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671812/ https://www.ncbi.nlm.nih.gov/pubmed/36138150 http://dx.doi.org/10.1038/s41591-022-01980-3 |
Ejemplares similares
-
The dopamine transporter gene SLC6A3: multidisease risks
por: Reith, Maarten E. A., et al.
Publicado: (2021) -
Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area Workshop
por: Stephenson, Diane, et al.
Publicado: (2023) -
Correction: Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area Workshop
por: Stephenson, Diane, et al.
Publicado: (2023) -
Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabwe
por: Ndlovu, Zibusiso, et al.
Publicado: (2018) -
Optogenetic control of Neisseria meningitidis Cas9 genome editing using an engineered, light-switchable anti-CRISPR protein
por: Hoffmann, Mareike D, et al.
Publicado: (2020)